SIETES :: 93212 citas

Resultados de la búsqueda por ANTIBIÓTICOS (2) REFINAR BÚSQUEDA

1.

Gopalakrishnan C, Bykov K, Fischer MA, Connolly JG, Gagne JJ, Fralick M. Association of fluoroquinolones with the risk of aortic aneurysm or aortic dissection. JAMA Intern Med 2020;180:8 de septiembre. [Ref.ID 103715]

2.

Dong Y-H, Chang C-H, Wang J-L, Wu L-C, Lin J-W, Toh S. Association of infections and use of fluoroquinolones with the risk of aortic aneurysm or aortic dissection. JAMA Intern Med 2020;180:8 de septiembre. [Ref.ID 103714]

3.

Haugaard JH, Kofoed K, Gislason G, Dreyer L, Egeberg A. Association between drug use and subsequent diagnosis of lupus erythematosus. JAMA Dermatol 2020;156:2 de septiembre. [Ref.ID 103711]

4.

Zaroff JG, Cheetham TC, Palmetto N, Almers L, Quesenberry C, Schneider J, Gatto N, Corley DA. Association of azithromycin use with cardiovascular mortality. JAMA Network Open 2020;3:17 de junio. [Ref.ID 103669]

5.

Nguyen LS, Dolladille C, Drici M-D, Fenioux C, Alexandre J, Mira J-P, Moslehi JJ, Roden DM, Funck-Brentano C, Salem J-E. Cardiovascular toxicities associated with hydroxychloroquine and azithromycin: an analysis of the World Health Organization pharmacovigilance database. Circulation 2020;142:22 de mayo. [Ref.ID 103660]

6.

Hill K, Sucha E, Rhodes E, Carrier M, Garg AX, Harel Z, Hundemer GL, Clark EG, Knoll G, McArthur E, Sood MM. Risk of hospitalization with hemorrhage among older adults taking clarithromycin vs azithromycin and direct oral anticoagulants. JAMA Intern Med 2020;180:agosto. [Ref.ID 103655]

7.

Borraz M, Ferrer S. Historia de un escándalo: una empresa sospechosa y el estudio que sacudió a la prestigiosa revista 'The Lancet' . eldiario.es 2020:6 de junio. [Ref.ID 103642]

8.

Mehra MR, Desai SS, Ruschitzka F, Patel AN. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet 2020:22 de mayo. [Ref.ID 103632]

9.

Chorin E, Dai M, Shulman E, Wadhwani L, Bar-Cohen R, Barbhaiya C, Aizer A, Holmes D, Bernstein S, Spinelli M, Park DS, Chinitz LA, Jankelson L. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin. Nat Med 2020:24 de abril. [Ref.ID 103600]

10.

Guh AY, Mu Y, Winston LG, Johnston H, Olson D, Farley MM, Wilson LE, Holzbauer SM, Phipps EC, Dumyati GK, Beldavs ZG, Kainer MA, et al.. Trends in U.S. burden of Clostridioides difficile infection and outcomes. N Engl J Med 2020;382:2 de abril. [Ref.ID 103578]

11.

Willems RPJ, van Dijk K, Ket JCF, Vandenbroucke-Grauls CMJE. Evaluation of the association between gastric acid suppression and risk of intestinal colonization with multidrug-resistant microorganisms. A systematic review and meta-analysis. JAMA Intern Med 2020;180:1 de abril. [Ref.ID 103547]

12.

Just KS, Dormann H, Böhme M, Schurig M, Schneider KL, Steffens M, Dunow S, Plank-Kiegele B, Ettrich K, Seufferlein T, Gräff I, Igel S, Schricker S, Jaeger SU, Schwab MStingl J. Personalising drug safety—results from the multi-centre prospective observational study on Adverse Drug Reactions in Emergency Departments (ADRED). Eur J Clin Pharmacol 2020;76:marzo. [Ref.ID 103531]

13.

Anónimo. FDA approves new treatment for adults with migraine. U.S. Food and Drug Administration 2019:23 de diciembre. [Ref.ID 103240]

14.

Castells M, Khan DA, Phillips EJ. Penicillin allergy. N Engl J Med 2019;381:12 de diciembre. [Ref.ID 103229]

15.

Teng C, Walter EA, Gaspar DKS, Obodozie-Ofoegbu OO, Frei CR. Torsades de pointes and QT prolongation associations with antibiotics: A pharmacovigilance study of the FDA adverse event reporting system. International Journal of Medical Sciences 2019;16:julio. [Ref.ID 103207]

16.

Rathi S, Kumar P. Drug-induced liver injury — Types and phenotypes. N Engl J Med 2019;381:3 de octubre. [Ref.ID 103189]

17.

Alves C, Mendes D, Batel Marques F. Fluoroquinolones and the risk of tendon injury: a systematic review and meta-analysis. Eur J Clin Pharmacol 2019;75:octubre. [Ref.ID 103186]

18.

Berghella V, Bellussi F. Antibiotics for operative vaginal delivery: practice-changing data. Lancet 2019;393:. [Ref.ID 103123]

19.

Knight M, Chiocchia V, Partlett C, Rivero-Arias O, Hua X, Hinshaw K, Tuffnell D, Linsell L, Juszczak E, on behalf of the ANODE collaborative group. Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trial. Lancet 2019;393:15 de junio. [Ref.ID 103118]

20.

Branch-Elliman W, O'Brien W, Strymish J, Itani K, Wyatt C, Gupta K. Association of duration and type of surgical prophylaxis with antimicrobial-associated adverse events. JAMA Surgery 2019:24 de abril. [Ref.ID 103091]